Zhang, C., Duan, S., Guo, M., Yuan, Y., Huang, Z., Zhu, J., . . . Xing, C. (2020). Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy. Pharmgenomics Pers Med.
Stile di citazione ChicagoZhang, Chengning, Suyan Duan, Miao Guo, Yanggang Yuan, Zhimin Huang, Jingfeng Zhu, Bin Sun, Bo Zhang, e Changying Xing. "Effects of CYP3A5 Polymorphisms On Efficacy and Safety of Tacrolimus Therapy in Patients With Idiopathic Membranous Nephropathy." Pharmgenomics Pers Med 2020.
Citazione MLAZhang, Chengning, et al. "Effects of CYP3A5 Polymorphisms On Efficacy and Safety of Tacrolimus Therapy in Patients With Idiopathic Membranous Nephropathy." Pharmgenomics Pers Med 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.